Navigation Links
Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
Date:11/1/2008

First Clinical Study of Paliperidone ER in this Under-Studied Condition

SAN DIEGO, Nov. 1 /PRNewswire/ -- Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a new study presented today at the U.S. Psychiatric & Mental Health Congress in San Diego, Calif.(1) In addition, safety findings were similar to published studies of paliperidone ER in the treatment of schizophrenia.(2)(3)

"Schizoaffective disorder is an under studied condition that despite being common among patients with serious mental illness, has no approved treatment," said Husseini Manji, M.D., Vice President, Central Nervous System and Pain, Johnson & Johnson Pharmaceutical Research and Development. "This new study suggests that paliperidone ER could be an effective option for the treatment of schizoaffective disorder. Additional studies are needed to confirm this finding."

Schizoaffective disorder is a condition, which encompasses the symptoms of both schizophrenia and a major mood disorder. Patients with schizoaffective disorder experience the psychosis characteristic of schizophrenia, such as hallucinations or delusions, as well as symptoms of mania and/or depression.(4) Schizoaffective disorder can be difficult to distinguish from schizophrenia or bipolar disorder because the symptoms are similar to both. The disorder is about one third as common as schizophrenia(5) but within those people that frequently use mental health services, schizophrenia and schizoaffective disorder may account for approximately 32% and 24% of cases respectively.(6)

In the 6 week, international, randomized, double-blind, placebo controlled study, 316 patients with an established diagnosis of schizoaffective disorder, who were experiencing acute symptoms, received either 6mg/day or 12mg/day paliperidone ER, or a placebo. Dosages could be reduced to 3mg/day or 9mg
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
2. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
3. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
4. Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
5. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
6. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
7. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
8. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
9. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
10. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
11. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors ... week at the 3M Championship Champions Tour event near ... in Blaine . Stryker is the official joint ... Starting Friday, August 1 st through Sunday, August ... Mobility Zone; an on-site joint health destination located in the Pioneer ...
(Date:7/30/2014)... , July 30, 2014 Silicon Valley Bank, ... a study today that examines the merger, acquisition ... device companies.  According to the annual report based on ... potential returns since SVB started tracking the data in ... IPO.  Built on solid healthcare M&A activity over the ...
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... the global leader in technology support and BPO services ... today the opening of its new Global Operations Center ... city of Dalian, will specialize in providing services in ... sponsors and clinical research organizations. With dramatic ...
... ARBOR, Mich., April 7, 2011 Adeona Pharmaceuticals, Inc. (AMEX: ... serious central nervous system diseases, announced today that it has ... its common stock at approximately $2.0725 per share to a ... million in gross proceeds. The investor will also receive warrants ...
Cached Medicine Technology:C3i Opens Asia Language Center in Dalian, China 2Adeona to Raise $3.5 Million in Registered Direct Offering 2Adeona to Raise $3.5 Million in Registered Direct Offering 3
(Date:7/30/2014)... The Europe commercial aviation actuation system market ... is expected to reach $1,686.72 million by 2019 at ... an exclusive range of opportunities and challenges which will ... has seen slumps in the past, yet the sector ... to its long-term growth rate of approximately 5 % ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Foot ... Seminar schedule, a series highlighted by eight speakers, 29 ... from seven chiropractic colleges. The seminars cover a range ... from low back stabilization to imaging. The Foot ... professionals by providing informative, entertaining courses that also offer ...
(Date:7/30/2014)... N.J. The household income of its residents is ... or low rates of avoidable hospital visits conditions that ... health care settings if treated at an early stage, according ... State Health Policy (CSHP). , An analysis of hospital ... low-income communities in New Jersey found that as an area,s ...
(Date:7/30/2014)... It is said that necessity is the ... true as a product sponsor for Lash Wars 2014 ... past June. , Lash Affair believes in the ... the eyelash industry through collaboration so Jenelle Paris, Founder and ... NEESA ’s event. Lash Affair’s mission dovetails nicely with ...
(Date:7/30/2014)... one in every twenty elderly American adults is being ... This burgeoning public health crisis especially affects poor and ... makers, researchers, and any citizen who cares about the ... Peterson of Weill Cornell Medical College in the US. ... on elder abuse, the findings of which appear in ...
Breaking Medicine News(10 mins):Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Aviation Actuation System Market is Expected to Reach $1,686.72 Million in 2019 - New Report by MicroMarket Monitor 4Health News:Foot Levelers Announces 2014 Fall Seminars Series Schedule 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 2Health News:Income is a major driver of avoidable hospitalizations across New Jersey 3Health News:Lash Affair Launches a New Product as Sponsor of the First U.S. Lash Extension Competition 2Health News:Older adults are at risk of financial abuse 2
... International SOS Assistance, Inc. today was awarded the ... Department of Defense TRICARE Overseas Program. Since 1998, International SOS ... and their families receive the highest quality care, no matter ... States and Puerto Rico. , Under this new ...
... given early in pregnancy might save infants most at ... -- U.S. researchers are testing a new approach in ... while they,re still in the womb. , The new ... cells that have been treated to speed and improve ...
... 16 The National Trauma Institute, a national non-profit ... States, announced its first Request for Proposals (RFP) for ... practice and save lives. , The organization will award ... take place in 2010. "Historically, trauma research has been ...
... THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Oct. 16 ... PFE ), today announced new scientific data about ENBREL ... (ACR) Scientific Meeting in Philadelphia, Pa., from Oct. 17-21, ... years of collective clinical experience. , "The ...
... public forum for discussing the latest updates, information on H1N1/Swine flu ... public are invited to submit questions for inclusion in a two-part ... 22, from 10 a.m. - noon on Twitter. , Sandro ... Health System and VA Ann Arbor Healthcare System, will answer questions ...
... comment on media reports this week that France is ... internet, to conform to European rights. Although Budget Minister ... news is disappointing given the drop in heart attack ... Professeur Ph.Gabriel STEG (Universit Paris VII, Centre Hospitalier Bichat-Claude ...
Cached Medicine News:Health News:International SOS Awarded TRICARE Overseas Program Contract 2Health News:Transplant May Treat Metabolic Disorders in Womb 2Health News:National Trauma Institute Announces $600,000 in Funding for Trauma Research 2Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 2Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 3Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 4Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 5Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 6Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 7Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 8Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 9Health News:ESC press statement : Cigarettes on sale on the internet 2Health News:ESC press statement : Cigarettes on sale on the internet 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: